We are live on ! Find out more
MRND

IQ U.S. Mid Cap R&D Leaders ETF
MRND

Delisted

MRND was delisted on the 12th of December, 2023.

Back to rankings

2 hedge funds and large institutions have $9.62M invested in IQ U.S. Mid Cap R&D Leaders ETF in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MSL
Mackay Shields LLC
New York
+$4.7M
2
NYLIM
New York Life Investment Management
New York
+$4.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MSL
1
Mackay Shields LLC
New York
$4.81M +$4.7M +190,000 New
NYLIM
2
New York Life Investment Management
New York
$4.81M +$4.7M +190,000 New

MRND Hedge Fund Activity: Q1 2022 in Review

2 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in IQ U.S. Mid Cap R&D Leaders ETF (MRND) for Q1 2022, worth a combined $9.62M.

Buyers outnumbered sellers: 2 funds opened new MRND positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Mackay Shields LLC, opening a new position worth an estimated $4.7M.

  • 2 institutional investors held IQ U.S. Mid Cap R&D Leaders ETF (MRND) as of Q1 2022, up from 0 in Q4 2021.
  • Funds reported $9.62M of IQ U.S. Mid Cap R&D Leaders ETF stock for Q1 2022.
  • 2 funds opened new IQ U.S. Mid Cap R&D Leaders ETF positions in Q1 2022 and 0 closed out, a net change of +2 holders.
  • The largest IQ U.S. Mid Cap R&D Leaders ETF buyer in Q1 2022 was Mackay Shields LLC, an estimated $4.7M added.

Based on aggregated 13F filings for Q1 2022.